2.11 Provisions, Contingent Liabilities and Contingent Assets
A provision is recognised when the Company has a present legal or constructive obligation as a result of a past event, and it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.
Contingent liabilities are disclosed when there is a possible obligation arising from past events, the existence of which will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the Company, or a present obligation that arises from past events where either the outflow of resources is not probable or the amount cannot be reliably estimated.
Contingent assets are not recognised in the financial statements but are disclosed when an inflow of economic benefits is probable.
Costs and expenses are recognised when incurred and have been classified according to their nature.
2.12 Income Taxes
Income tax comprises of current tax and deferred tax.
a. Current Tax
Current income tax for the current and prior periods are measured at the amount expected to be recovered from or paid to the taxation authorities based on the taxable profit for the period. The tax rates and tax laws used to compute the amount are those that are enacted by the reporting date and applicable for the period. The Company offsets current tax assets and current tax liabilities where it has a legally enforceable right to set off the recognised amounts and where it intends either to settle on a net basis, or to realise the asset and liability simultaneously.
b. Deferred tax
Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities in the Balance Sheet and their tax bases. Deferred tax liabilities are recognised for all taxable temporary differences. Deferred tax assets are recognised for all deductible temporary differences and incurred tax losses to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. Such deferred tax assets and liabilities are not recognised if the temporary difference arises from the initial recognition (other than in a business combination) of assets and liabilities in a transaction that affects neither the taxable profit nor the accounting profit.
Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that
have been enacted or substantively enacted by the end of the reporting period.
The carrying amount of deferred income tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred income tax asset to be utilised.
The Company recognises deferred tax liabilities for all taxable temporary differences except those associated with the investments in subsidiaries where the timing of the reversal of the temporary difference can be controlled and it is probable that the temporary difference will not reverse in the foreseeable future.
2.13 Foreign currency Transactions
(a) Functional and presentation currency: Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates ('the functional currency'). The financial statements are presented in Indian rupee (INR), which is the Company's functional and presentation currency.
(b) Transactions and balances: On initial recognition, all foreign currency transactions are recorded by applying to the foreign currency amount, the exchange rate between the functional currency and the foreign currency at the date of the transaction. Gains/Losses arising out of fluctuation in foreign exchange rate between the transaction date and settlement date are recognised in the Statement of profit and loss. All monetary assets and liabilities in foreign currencies are restated at the year end at the exchange rate prevailing at the year end and the exchange differences are recognised in the Statement of profit and loss. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the initial transactions.
3 CHANGES IN ACCOUNTING POLICIES AND DISCLOSURES(i) New standards and amendments issued but not effective
During the year, the Ministry of Corporate Affairs ("MCA") notified amendments to various Indian Accounting Standards through the Companies
(Indian Accounting Standards) Amendment Rules, 2025 and the Companies (Indian Accounting Standards) Second Amendment Rules, 2025, effective for annual reporting periods beginning on or after 01 April, 2025.
The amendments include:
(a) Ind AS 7 - Statement of Cash Flows and Ind AS 107 - Financial Instruments: Disclosures relating to Supplier Finance Arrangements, requiring additional disclosures to enable users of financial statements to understand the effects of supplier finance arrangements on an entity's liabilities, cash flows and exposure to liquidity risk.
(b) Ind AS 1 - Presentation of Financial Statements relating to Classification of Liabilities as Current or Non-current and Non-current Liabilities with Covenants, clarifying the requirements for classification of liabilities and the assessment of covenant conditions.
(c) Ind AS 12 - Income Taxes relating to Pillar Two Tax Reforms.
(d) Ind AS 21 - The Effects of Changes in Foreign Exchange Rates relating to Lack of Exchangeability, providing guidance on determining exchange rates when a currency is not exchangeable into another currency.
The Company has assessed the impact of the above amendments and concluded that they do not have any material impact on its financial statements, financial position, results of operations, cash flows or disclosures for the year ended 31 March, 2026.
Further, MCA has notified additional amendments to Ind AS 1 - Presentation of Financial Statements relating to the classification of liabilities as current or non-current and non-current liabilities with covenants, effective for annual reporting periods beginning on or after 01 April, 2026. The Company has evaluated these amendments and does not expect them to have any material impact on its financial statements upon adoption.
Notes for changes in current year
* On 30 April, 2025, the Company invested in 8,93,334 equity shares of Bizdent Devices Private Limited having a face value of INR 10 each, issued at a premium of INR 458 per share, aggregating to a total investment amount of INR 409.15 million.
** On 24 April, 2025, the Company invested in 10,000 equity shares of Laxmi Dental Lab USA, INC having a face value of USD 100 each, amounting to INR 85.70 million.
*** On 18 September, 2025, the Company invested INR 13.72 million in 11,175 equity shares and INR 6.29 million in 5,123 Compulsorily Convertible Preference Shares (CCPS) of IDBG AI Dent Global Private Limited, each having a face value of INR 10 and issued at a premium of INR 1,217.5 per share.
7.1 Investment in Joint Venture(a) Kids-e Dental LLP is a separate structure entity incorporated and operating in India.
The contractual arrangements provides the Company with the right to take material decision jointly along with one of the designated partner of the LLP. Under the Ind AS 111, this joint arrangement is classified as a joint venture.
Notes:
1 In line with Circular No 04/2015 issued by Ministry of Corporate Affairs dated 10 March, 2015, loans given to employees as per the Company's policy are not considered for the purposes of disclosure under Section 186(4) of the Companies Act, 2013.
2 There are no loans or advances in the nature of loans granted to Promoters, Directors, KMPs and their related parties (as defined under Companies Act, 2013), either severally or jointly with any other person, that are:
(a) repayable on demand; or (b) without specifying any terms or period of repayment.
3 There are no loans which have significant increase in credit risk and which are credit impaired.
a) During the previous year, the Company issued shares against the Share Swap Agreement with NCI's shareholder of Bizdent Devices Private Limited, issuing 1,146 equity shares with a face value of INR 10 each.
b) During the previous year, pursuant to resolution passed by the Board of Directors at their meeting dated 04 June, 2024, and the Shareholders at their EGM dated 07 June, 2024, the share capital of Company was split from 3,09,060 equity shares of face value of INR10 each to 15,45,300 Equity Shares of face value of INR 2 each.
c) During the previous year, The Board of Directors approved the issuance of bonus equity shares, which was subsequently approved by the shareholders in the meeting held on 07 June, 2024. The bonus issue was in the ratio of 17 equity share of INR 2 for every 1 equity shares of INR 2, by capitalising the free reserves of the Company. A total of 2,62,70,100 bonus shares were issued (Face Value of INR 2 each).
d) During the previous year, the Company issued fresh issue of equity shares 32,24,299 with a face value of INR 2 each. (For IPO proceeds utilisation refer note 49)
(ii) Rights, preferences and restrictions attached to the equity shares:
The Company has only one class of equity shares having par value of INR 2 per share. Each shareholder is entitled to one vote per share held. The Company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting.
During the year ended 31 March, 2026, the amount of per share dividend recognised as distributions to equity shareholders was Nil (previous year: Nil).
In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.
* Mr. Sameer Merchant, Promoter of the Company had purchased 17,179 equity shares on 30 March, 2026, however the same was not reflected on 31 March, 2026 statement because of T 1 Settlement cycle.
Note:
As per records of the Company, including its register of shareholders/ members and other declarations received from shareholders regarding beneficial interest, the above shareholding represents both legal and beneficial ownerships of shares.
(iv) The Company has not issued any bonus shares or shares for consideration other than cash during the five years immediately preceding the reporting date, except that the Board of Directors approved the issue of bonus equity shares, which was subsequently approved by the shareholders at their meeting held on 07 June, 2024. The bonus issue was in the ratio of 17 equity shares of INR 2 each for every 1 equity share of INR 2 each, by capitalisation of the free reserves of the Company.
(v) The Company has not bought back any shares during the period of five years immediately preceding the current year end.
(vi) Details of Shares held by promoters at the end of the year :
(ii) Rights, preferences and restrictions attached to the preference shares:
Each shareholder is eligible to vote in the ratio of their shareholding. The holders of CCPS shall be entitled to vote on all such matters which affect their rights directly or indirectly.
The Investor Shares shall rank senior to the preference shares and other instruments that are outstanding and which may be issued by the Company from time to time in all respects including but not limited to voting rights, dividends and liquidation/ liquidity preference and bonus issuances. The holders of Series A CCPS shall be entitled to all superior rights or other rights that may be given to any other investor, if any, in the future.
The Series A CCPS shall carry a pre-determined cumulative dividend rate of 0.0001% (zero point zero zero zero one percent) per annum. In addition to the same, if the holders of Equity Shares are paid dividend in excess of 0.0001% (zero point zero zero zero one percent) per annum, the holders of the Series A CCPS shall be entitled to dividend at such higher rate.
The holder of the Series A CCPS shall have the right to be first paid, in priority to the other Shareholders and all other classes of preference shareholders, any declared but accrued and unpaid dividends.
The holders of Investor CCPS shall, at any time prior to 19 (nineteen) years from the date of issuance of the same, be entitled to call upon the Company to convert all or any of the Investor CCPS and if not converted earlier, shall automatically convert into Equity Shares at the fixed conversion rate (1:0.9147), (i) on latest permissible date prior to the issue of Shares to the public in connection with the occurrence of a Public Offer under Applicable Law, or (ii) on the day following the completion of 19 (nineteen) years from the date of issuance of the same.
19 LEASES
The Company has lease contracts for office premises used in its operations. Lease terms generally ranges between 1 and 5 years.
The Company assesses whether a contract contains a lease, at inception of a contract. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
The Company also has certain lease of Property with lease term upto 12 months (Short Term Leases) hence the Company applies the recognition exemption related to short term leases for these leases.
F Performance Obligation :
The majority of the Company's revenue is derived from setting goods with revenue recognised at a point in time when control of the goods has transferred to the customer.This is generally when the goods are delivered to the customer. However, for export sates, control might also be transferred when delivered either to the port of departure or port of arrival, depending on the specific terms of the contract with a customer. There is limited judgement needed in identifying the point control passes: once physical delivery of the products to the agreed location has occurred, the Company no longer has physical possession, usually witt have a present right to payment (as a single payment on delivery) and retains none of the significant risks and rewards of the goods in question.
35.1 During the previous year, On 07 May, 2024 the Company sold one of its Investment properties Gala No. 105, 106 & 107, Shreyas Building, Survey No. 41, Off Link road, Oshiwara, Andheri(W), Maharashtra, 400053 to Siddhi Leela Properties at the sale consideration of INR 101 million. The book value of the aforesaid Property as on the date of sale was INR 7.10 million. The Company accounted for difference between the sale consideration and book value as gain on sale of Investment property INR 93.90 million. The Tax arising on account of the transaction was INR 23.64 million. The Company has disclosed the gain on account of this transaction (net of tax) amounting to INR 70.27 million as an exceptional gain.
35.2 Effective 21 November, 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes has resulted in material increase in provision for gratuity expenses on account of recognition of past service costs. Based on the requirements of New Labour Codes and relevant Accounting Standard, the Company has assessed and accounted the estimated incremental impact of INR 51.56 million as an Exceptional Item in the standalone financial statements for the year ended 31 March, 2026. Upon notification of the related Rules to the New Labour Codes by the Government and any further clarification from the Government on other aspects of the New Labour Codes, the Company will evaluate and account for additional impact if any, in subsequent periods.
During the previous year, unabsorbed depreciation at the beginning of the year amounted to INR 58.55 million has been bifurcated based on the utilisation between normal income and exceptional income as referred in note no.35.1
During the year ended 31 March, 2025, the Company has opted to avail benefit of section 115BAA and the corresponding revision has been considered in the current tax and deferred tax accordingly.
37 EARNINGS PER SHARE (EPS)
Basic/Diluted earnings per share amounts are calculated by dividing the profit for the year attributable to equity holders by the weighted average number of equity shares outstanding during the year.
Note :
1 Refer Note 17 A(i) (a),(b)and (c), regarding details of Split of equity shares, issue of Bonus Shares and Private Placement. Effect of same has been considered while calculating the Weighted Average Number of equity shares.
2 On 07 June, 2024, the Board of Directors approved the sub-division of each equity share of face value INR 10 fully paid up into 5 equity shares of face value INR 2 fully paid up. Consequently, the number of equity shares has increased from 309,060 shares of face value INR 10 each to 1,545,300 shares of face value INR 2 each.
3 Further, the Board of Directors, in their meeting held on 07 June, 2024, approved the issue of bonus equity shares in the ratio of 1 equity share of INR 2 each for every 17 equity shares of INR 2 each by capitalisation of the free reserves of the Company. As a result, 15,45,300 equity shares have been subdivided into 2,62,70,100 equity shares.
4 During the previous year, the Board of Directors and Shareholders of the Company has approved the Employee Stock Option Plan 2024 (''ESOP 2024") for the employees of the Company and its subsidiary companies comprising of equity shares of the Company, not exceeding 5,00,000 equity shares of face value of INR 2/- each. The Company has granted 3,51,672 equity shares of face value of INR 2/- each on 14 December, 2024 to its eligible employees. Effect of same has been considered while calculating the Dilutive effect of Weighted average Number of equity shares.
5 Subsequently, 44,788 stock options granted under ESOP 2024 were forfeited due to cessation of employment and/ or non-fulfilment of vesting conditions/surrender by employees. The effect of such forfeiture has been appropriately considered in the financial statements.
38 EMPLOYEE BENEFITS OBLIGATIONS(I) Defined contributions plans - provident fund and others
The Company operates defined contribution plans such as the Employees' Provident Fund (EPF) in accordance with the provisions of the Employees' Provident Funds and Miscellaneous Provisions Act, 1952. Under these schemes, the Company is required to contribute a specified percentage of payroll costs to the respective funds.
In accordance with Ind AS 19 Employee Benefits, contributions to defined contribution plans are recognised as an expense in the Statement of Profit and Loss in the period in which the related employee services are rendered. The Company has no further obligations beyond its contributions to such plans.
(II) Defined benefit plans (A) Gratuity
The Company provides for gratuity benefit under a defined benefit retirement plan ("the Gratuity Scheme") in accordance with the provisions of the Code on Social Security, 2020. The scheme covers eligible employees, and the eligibility, benefit structure, and computation of gratuity are determined based on the provisions of the said Code, including the definition of "wages" as prescribed therein.
The level of benefits provided depends on the employee's length of service and last drawn eligible wages at the time of separation.
In accordance with Ind AS 19 Employee Benefits, the gratuity obligation is recognised as a defined benefit liability and is measured using the projected unit credit method at the end of each reporting period.
The scheme is funded in nature, and plan assets have been created.
The Company recognises actuarial gains and losses in Other Comprehensive Income in the period in which they arise.
The sensitivity analysis have been determined based on reasonably possible changes of the respective assumptions occurring at the end of the reporting period, while holding all other assumptions constant.
The sensitivity analysis presented above may not be representative of the actual change in the Defined Benefit Obligation as it is unlikely that the change in assumptions would occur in isolation of one another as some of the assumptions may be correlated.
Furthermore, in presenting the above sensitivity analysis, the present value of the Defined Benefit Obligation has been calculated using the projected unit credit method at the end of the reporting period, which is the same method as applied in calculating the Defined Benefit Obligation as recognised in the balance sheet. The sensitivity analysis presented above may not be representative of the actual change in the Defined Benefit Obligation as it is unlikely that the change in assumptions would occur in isolation of one another as some of the assumptions may be correlated.
There was no change in the methods and assumptions used in preparing the sensitivity analysis from prior years.
(iii) Compensated absences
The obligation for compensated absences as at year end amounts to INR 3.09 million (31 March, 2025: INR 6.90 million). The charge towards compensated absences for the year ended 31 March, 2026 based on actuarial valuation is INR (3.85) million (31 March, 2025: INR 3.16 million).
Note:
1 Reimbursement of expenses in normal course of business have not been included herein above.
2 Sales of goods to related parties were made at the Company's usual list prices, that prevail in arm's length transactions. Purchases were made at market prices. Outstanding balances at the year-end with related parties are unsecured and interest free (other than loans at market rates) to be settled in cash in the next three months The Company has not made any allowance for bad or doubtful debts in respect of related party trade receivables nor has any guarantee been given or received during the year ended 31 March, 2026 and 31 March, 2025 relating to related party transactions.
In the course of its business, the Company is exposed primarily to liquidity risk, interest rate fluctuation risk, credit risk and foreign exchange fluctuation risk.
A Liquidity risk
Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are proposed to be settled by delivering cash or other financial asset. The Company's financial planning has ensured, as far as possible, that there is sufficient liquidity to meet the liabilities whenever due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company's reputation. The Company has practiced financial diligence and syndicated adequate liquidity in all business scenarios.
B Interest rate risk
Interest rate risk can be either fair value interest rate risk or cash flow interest rate risk. Fair value interest rate risk is the risk of changes in fair value of fixed interest bearing investments because of fluctuations in the interest rates. Cash flow interest rate risk is the risk that the future cash flows of floating interest bearing investments will fluctuate because of fluctuations in the interest rates.
The Company manages its interest rate risk by having a balanced portfolio of fixed and variable rate loans and borrowings.
C Credit risk
Credit risk arises from the possibility that customers may not be able to settle their obligations as agreed. Trade receivables are typically unsecured and are derived from revenue earned from customers located in India. Credit risk is managed through periodic assessment of the financial reliability of customers, taking into account the financial condition, current economic trends, analysis of historical bad debts and ageing of trade receivables. Other financial instruments that are subject to credit risk includes cash and cash equivalents, bank deposits, loans and security deposits.
The Company uses Expected Credit Loss model to assess the impairment loss. The Company computes the expected credit loss allowance as per simplified approach for trade receivables based on available external and internal credit risk factors such as the ageing of its dues, market information about the customer and the Company's historical experience for customers. The Company has used a practical expedient by computing the expected credit loss allowance for trade receivables based on a provision matrix. The provision matrix takes into account historical credit loss experience and is based on the ageing of the receivable days and the rates as given in the provision matrix.
ii) The credit risk on cash and cash equivalents and bank deposits is limited because the counterparties are banks with high credit ratings.
The maximum exposure to credit risk is equal to the carrying value of the financial assets. The objective of managing counterparty credit risk is to prevent losses in financial assets. The Company assesses the credit quality of the counterparties, taking into account their financial position, past experience and other factors.
iii) The Company does a credibility check on the landlords before taking any property on lease and hasn't had a single instance of non-refund of security deposit on vacating the leased property. The Group also in some cases ensure that the notice period rentals are adjusted against the security deposits and only differential, if any, is paid out thereby further mitigating the non-realisation risk.
D Foreign currency risk
Foreign currency risk is the risk that the Fair Value or Future Cash Flows of an exposure will fluctuate because of changes in foreign currency rates. Exposures can arise on account of the various assets and liabilities which are denominated in currencies other than Indian Rupee. The following table shows in million, the US Dollar currency exposure on financial instruments at the end of the reporting period.
For the purpose of the Company's capital management, capital includes issued equity capital, securities premium and all other equity reserves attributable to the equity holders. The primary objective of the Company's capital management is to maintain a strong capital base to ensure sustained growth in business and to maximize the shareholders value and to ensure the Company's ability to continue as a going concern. The capital management focuses to maintain an optimal structure that balances growth and maximizes shareholder value.
The Company has not declared or paid any dividend to its shareholders during the year. The Company monitors its capital structure through the gearing ratio, which represents total debt as a proportion of total capital (equity and debt). Total debt comprises non-current borrowings representing the liability component of Convertible Preference Shares and current borrowings from the Company's ultimate holding company. The Company manages and adjusts its capital structure in response to changes in economic conditions and the risk profile of the underlying assets, with the objective of maintaining an optimal balance between debt and equity.
44 CORPORATE SOCIAL RESPONSIBILITY (CSR)
As per Section 135 of the Companies Act, 2013, during the year, Company is required to comply with the CSR requirements which is formation of the CSR committee, identification of the CSR projects and funding such projects for at least two percent of the average net profits of the Company made during the three immediately preceding financial years. The funds
45 SHARE BASED PAYMENTSEmployee share option plan (ESOP)
The shareholder of the Company have vide their special resolution dated 16 August, 2024 approved the Laxmi Dental Employee Stock Option Scheme 2024 ("ESOP2024"/"Scheme")scheme authorizing the Board for granting Employee Stock Options in form of equity shares linked to the completion of a minimum period of continued employment to the eligible employees of the Company, monitored and supervised by the Board of Directors. The employees can purchase equity shares by exercising the options as vested at the price specified in the plan.
1 The Company provided the ESOPs to the one of the subsidiary company i.e. Bizdent Devices Private Limited
2 The Company has received in-principle approvals from National Stock Exchange of India Limited and BSE Limited vide their letters dated 08 April, 2026 and 10 April, 2026, respectively, for the listing of up to a maximum of 500,000 equity shares of face value of INR 2/- each, proposed to be allotted under the ''Laxmi Dental Stock Option Scheme 2024"
iii. Utilisation of funds
No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities ("Intermediaries") with the understanding, whether recorded in writing or otherwise, that the Intermediary shall lend or invest in party identified by or on behalf of the Company (Ultimate Beneficiaries).
The Company has not received any fund from any party(s) (Funding Party) with the understanding that the Company shall whether, directly or indirectly lend or invest in other persons or entities identified by or on behalf of the Company ("Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
iv. Details of benami property held
The Company does not have any Benami property, where any proceeding has been initiated or pending against the Company for holding any Benami property.
v. Wilful Defaulter
The Company has not defaulted nor been declared wilful defaulter by any bank or financial institution or other lender.
vi. Quarterly Returns
The Company had availed loans from banks on the basis of security of current assets. The Company files statement of current assets with the bank on periodical basis. Reconciliation of quarterly returns or statements of current assets filed with banks or financial institutions.
The reason for reconciliation between quarterly returns or statements of current assets filed with banks are as follows:
1) Inventories:
a. Adjustments arising from the application of sales cut-off procedures.
b. Provision for slow moving, non-moving.
2. ) Trade Receivables:
a. Loss allowance made for trade receivables.
b. Adjustments to trade receivables due to period-end cut-off procedures.
c. Remeasurement of balances due to foreign exchange rate fluctuations.
d. Offsetting advance from customers against trade receivables.
3. ) Trade Payables:
a. Offsetting advance to suppliers against trade payable.
Note : The Company has fully repaid such borrowings in February 2025. Accordingly, as at 31 March, 2026, the Company does not have any borrowings secured against current assets. Hence, reporting requirements relating to reconciliation of quarterly returns/statements of current assets filed with banks or financial institutions are not applicable.
vii. Transaction with struck off companies
The Company has not entered into any transactions with companies struck off under Section 248 of the Companies Act, 2013 or Section 560 of the Companies Act, 1956 during the year ended 31 March, 2026.
viii. Registration of charges or satisfaction with Registrar of Companies (ROC)
The Company does not have any charges or satisfaction which is yet to be registered with ROC beyond the statutory period.
ix. Compliance with number of layers of companies
The Company has complied with the number of layers prescribed under clause (87) of section 2 of the Act read with Companies (Restriction on number of Layers) Rules, 2017.
x. Compliance with approved Scheme(s) of Arrangements
The Company has not entered into any scheme of arrangements as approved by the competent authority in terms of Section 230 to 237 of the Companies Act, 2013, thus, the disclosures relating to compliance with approved scheme of arrangements is not applicable to the Company, other than as disclosed in note 50.
xi Undisclosed income
The Company does not have any undisclosed income which is not recorded in the books of account that has been surrendered or disclosed as income during the year (previous year) in the tax assessments under the Income Tax Act, 1961.
xii Details of Crypto Currency or Virtual Currency
The Company has not traded or invested in crypto currency or virtual currency during the current or previous year.
48 The Company has used accounting software for maintaining its books of account for the financial year ended 31 March, 2026, namely Zoho Books, which has a feature of recording audit trail (edit log) facility. The audit trail feature was enabled and operated throughout the year for all relevant transactions recorded in the software, and the audit trail has been preserved by the Company as per the statutory requirements.
49 During the year ended 31 March, 2025, the Company has completed an Initial Public Offer of 1,63,09,766 equity shares of face value of INR 2/- each comprising of (i) fresh issue of 32,24,299 equity shares at an issue price of INR 428 per equity share aggregating to INR1,380 million, and (ii) an offer for sale of 1,30,85,467 equity shares at an issue price of INR 428 per equity share aggregating to INR 5,600.58 million and listed on both Bombay Stock Exchange Limited (BSE) and National Stock Exchange (NSE) on 20 January, 2025. The Company has received gross proceeds from fresh issue of INR 1,380.00 million against which Company has incurred an estimated issue related expenses (net off tax) of INR 92.29 million.
Out of the net proceeds which were unutilised as at 31 March, 2026, INR 546.63 million are temporarily invested in fixed deposits with banks.
The Company is in the process of obtaining an extension for the utilisation of the IPO proceeds in the subsequent period.
50 During the year ended 31 March, 2026, the Board of Directors approved the Scheme of Merger of Bizdent Devices Private Limited, a wholly owned subsidiary, with the Company, Laxmi Dental Limited. The Scheme provides for merger of the business of Bizdent Devices Private Limited, subject to receipt of requisite statutory and regulatory approvals. As the Scheme is currently awaiting approval from the appropriate authorities, no effect of the proposed merger has been given in these standalone financial statements.
|